Cart
sales@molnova.com
(-)-Syringaresinol
CAS No. 6216-81-5
(-)-Syringaresinol( Lirioresinol b | DL-Syringaresinol )
Catalog No. M29024 CAS No. 6216-81-5
(-)-Syringaresinol is derived from the stems of Annona Montana. (-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G1 arrest and induction of apoptosis and possesses anti-cancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 86 | Get Quote |
|
| 5MG | 155 | Get Quote |
|
| 10MG | 244 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(-)-Syringaresinol
-
NoteResearch use only, not for human use.
-
Brief Description(-)-Syringaresinol is derived from the stems of Annona Montana. (-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G1 arrest and induction of apoptosis and possesses anti-cancer activity.
-
Description(-)-Syringaresinol is derived from the stems of Annona Montana. (-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G1 arrest and induction of apoptosis and possesses anti-cancer activity.
-
In Vitro——
-
In Vivo——
-
SynonymsLirioresinol b | DL-Syringaresinol
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6216-81-5
-
Formula Weight418.44
-
Molecular FormulaC22H26O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (238.98 mM)
-
SMILESO(C)C=1C=C([C@]2([C@]3([C@]([C@@](OC3)(C4=CC(OC)=C(O)C(OC)=C4)[H])(CO2)[H])[H])[H])C=C(OC)C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BPH-715
BPH-715 inhibits the liver-stage growth of P. falciparum with an IC50 of 10 μM for P. falciparum exoerythrocytic forms in HepG2 cells.
-
3-Hydroxy-2-methylpy...
3-Hydroxy-2-methylpyridine could as a promising molecular scaffold for the future development of novel fibrillization inhibitors.
-
EPZ032597
EPZ032597 is a novel selective inhibitor of SMYD2 with an IC50 of 16 nM. EPZ032597 has anticancer activity and can be used to prevent and treat pancreatic cancer.
